LBA64nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study. (23rd October 2018) - Spigel, D R; Jotte, R M; Ponce Aix, S; Gressot, L; Morgensztern, D; McCleod, M; Socinski, M A; Daniel, D; Juan-Vidal, O; Kim, E S; West, H J; Chen, T; et al.